Gwen Fewell

With over 15 years experience in startup biotechnology and life science research market Gwen is a domain expert in both the technologies and market dynamics. Gwen co-founded transOMIC technologies, a research tools company specializing in gene manipulation technologies where she led corporate strategy and commercial operations and serves on the Board of Directors. Gwen has a wealth of experience driving commercial strategy at both startup and large companies. Previously she led global product marketing of the RNAi and Gene Expression portfolio at Thermo Scientific Genomics and was Director of Product Marketing at Open Biosystems where she led product management and marketing teams with responsibility for commercializing new gene modulation products including the first vector-based RNAi whole genome product on the market. Gwen was awarded the 2014 State of Alabama Innovation Award for Outstanding Woman in Innovation. Gwen earned an M.S in Neurophysiology from University of Mumbai and a PhD in Neuroscience at Florida State University. She performed postdoctoral studies at Children’s Hospital, Cincinnati exploring the genetic role of homeobox genes in brain development and later studied the genetics of pediatric medulloblastoma in the Department of NeuroOncology at MD Anderson Cancer Center in Houston, TX.